Plasmodium falciparum gametocyte carriage is associated with subsequent plasmodium vivax relapse after treatment

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Lin, Jessica T ^a,e   Bethell, Delia ^a   Tyner, Stuart D ^a   Lon, Chanthap ^a   Shah, Naman K ^d   Saunders, David L ^a   Sriwichai, Sabaithip ^a   Khemawoot, Phisit ^a   Kuntawunggin, Worachet ^a   Smith, Bryan L ^a   Noedl, Harald ^c   Schaecher, Kurt ^a   Socheat, Duong ^b   Se, Youry ^a   Meshnick, Steven R ^d   Fukuda, Mark M ^a,f  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d IL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f Armed Forces Health Surveillance Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; QUININE; TETRACYCLINE; ANTIMALARIAL AGENT;

ADULT; AGE; ARTICLE; BLOOD SMEAR; CAMBODIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GAMETOCYTE; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEDICAL HISTORY; MICROSCOPY; MIXED INFECTION; MOLECULAR DIAGNOSIS; PARASITE IDENTIFICATION; PARASITE IMMUNITY; PARASITE LOCALIZATION; PARASITE VECTOR; PARASITEMIA; PLASMODIUM VIVAX MALARIA; RECURRENT INFECTION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; ISOLATION AND PURIFICATION; MALARIA; PARASITOLOGY; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RECURRENT DISEASE;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

ADULT; ANTIMALARIALS; CAMBODIA; FEMALE; HUMANS; MALARIA; MALE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 79955390430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018716     Document Type: Article

References (22)

1. Mayxay M, Pukrittayakamee S, Newton PN, White NJ, (2004) Mixed-species malaria infections in humans. Trends Parasitol 20: 233-40.
2. Snounou G, White NJ, (2004) The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 20: 333-9.
3. Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ, (2004) Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 89: 351-6.
4. Looareesuwan S, White NJ, Chittamas S, Bunnag D, Harinasuta T, (1987) High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet 2: 1052-5.
5. Bunnag D, Viravan C, Looareesuwan S, Karbwang J, Harinasuta T, (1991) Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J Trop Med Public Health 22: 534-8.
6. Hasugian AR, Purba HL, Kenangalem E, Wuwung RM, Ebsworth EP, et al. (2007) Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria. Clin Infect Dis 44: 1067-74.
7. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, et al. (2009) Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 4: e6358.
8. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, et al. (2010) Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 10: 677-81.
9. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, et al. (2011) Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis 52: 612-20.
10. Price RN, Douglas NM, (2010) Maximising the public health benefit of antimalarials. Lancet Infect Dis 10: 654-5.
11. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, et al. (2010) Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clin Infect Dis 51: e82-9.
12. Se Y, Lon C, Socheat D, Bethell D, Sriwichai S, et al. (2009) Effects of Increasing Artesunate Dose in Seven-Day Monotherapy Regimens on Treatment Response in Cambodian Patients with Uncomplicated Falciparum Malaria. Presented at Annual Meeting of American Society of Tropical Medicine and Hygiene, Nov 19, 2009.
13. Rougemont M, Van Saanen M, Sahli R, Hinrison HP, Bille J, et al. (2004) Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR Assays. J Clin Microbiol 42: 5636-43.
14. Mlambo G, Vasquez Y, LeBlanc R, Sullivan D, Kumar N, (2008) A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg 78: 114-6.
15. Noedl H, Teja-Isavadharm P, Miller RS, (2004) Nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma. Antimicrob Agents Chemother 48: 4485-7.
16. Dixon MW, Thompson J, Gardiner DL, Trenholme KR, (2008) Sex in Plasmodium: a sign of commitment. Trends Parasitol 24: 168-75.
17. McKenzie FE, Jeffery GM, Collins WE, (2002) Plasmodium malariae infection boosts Plasmodium falciparum gametocyte production. Am J Trop Med Hyg 67: 411-4.
18. Bousema JT, Drakeley CJ, Mens PF, Arens T, Houben R, et al. (2008) Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. Am J Trop Med Hyg 78: 442-8.
19. Boyd MF, Kitchen SF, (1938) Vernal vivax activity in persons simultaneously inoculated with Plasmodium vivax and Plasmodium falciparum. Am J Trop Med Parasitol 18: 505-514.
20. Zimmerman PA, Mehlotra RK, Kasehagen LJ, Kazura JW, (2004) Why do we need to know more about mixed Plasmodium species infections in humans? Trends Parasitol 20: 440-7.
21. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, et al. (2000) Cross-species interactions between malaria parasites in humans. Science 287: 845-8.
22. Baird JK, (2011) Radical cure: the case for anti-relapse therapy against all malarias. Clin Infect Dis 52: 621-23.